| Outcomes in metastatic pancreatic adenocarcinoma (MPAC) patients treated with FOLFIRINOX (FFX)/FOLFOX (FX) and gemcitabine+ nab-paclitaxel (NabG). SL Schmidt, V Durkal, S Pattali Jayavalsan, JP Thomas, PS Ritch, ... Journal of Clinical Oncology 34 (4_suppl), 397-397, 2016 | 6 | 2016 |
| A Retrospective Analysis of All Hematological Malignancies in Patients Infected with HIV, a Subset Analysis of the CHAMP Study (Cook County Hospital (CCH) AIDS Malignancy Project) SGSJSSSSSPTBMTAFPG Rubinstein blood 118 (21), 3693-3693, 2011 | 3 | 2011 |
| Can response to treatment predict outcome in patients with metastatic pancreatic adenocarcinoma (MPAC)? S Pattali Jayavalsan, SL Schmidt, V Durkal, PS Ritch, JP Thomas, ... Journal of Clinical Oncology 34 (4_suppl), 443-443, 2016 | 2 | 2016 |
| Can the sequence of chemotherapy regimens influence outcome in patients with metastatic pancreatic adenocarcinoma (MPAC)? SL Schmidt, V Durkal, S Pattali Jayavalsan, PS Ritch, JP Thomas, ... Journal of Clinical Oncology 34 (4_suppl), 428-428, 2016 | 2 | 2016 |
| Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for invasive anal carcinoma in HIV-positive patients receiving highly active anti-retroviral therapy versus non … PG Rubinstein, SB Sreenivasappa, S Gupta, S Jain, S Pattali, J Blumetti, ... Journal of Clinical Oncology 30 (15_suppl), e14590-e14590, 2012 | 2 | 2012 |
| Value of mitotic index in residual tumors following neoadjuvant therapy for breast cancer: Single institution experience. S Pattali, N Harding, A Visotcky, Z Basir, JA Charlson, YC Cheng, ... Journal of Clinical Oncology 34 (15_suppl), 548-548, 2016 | 1 | 2016 |
| Factors Affecting Overall Survival in a Minority-based Population of Young Colorectal Cancer Patients: A Single-institution Multivariate Analysis: 2067 K Agrawal, S Jain, S Pattali, A Singh, K Agrawal, B Cleveland, M Mullane Official journal of the American College of Gastroenterology| ACG 108, S628, 2013 | 1 | 2013 |
| Multivariate analysis of factors affecting overall survival in minority-based population of young colorectal cancer patients: A single-institution experience. S Jain, K Agrawal, S Pattali, A Singh, K Agrawal, B Cleveland, ... Journal of Clinical Oncology 30 (15_suppl), e14186-e14186, 2012 | 1 | 2012 |
| Chronic Myelogenous Leukemia in the Era of Tyrosine Kinase Inhibitors: Is Sokal Score Still a Valid Predictor of Prognosis? S Jain, K Agrawal, A Singh, S Pattali, A Haidau, P Kovarik, ... Blood 120 (21), 4422, 2012 | | 2012 |
| CHRONIC MYELOGENOUS LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS: SOKAL SCORE STILL HOLDS? S Jain, A Singh, S Pattali, K Agrawal, K Agrawal, A Haidau, ... EXPERIMENTAL HEMATOLOGY 40 (8), S152-S152, 2012 | | 2012 |
| Prospective Study to Evaluate the Efficacy and Safety of Gemcitabine Combined with GMCSF and Rituximab in Heavily Pre-Treated Relapsed/Refractory B-Lymphoproliferative Disorders S Pattali, SA Gregory, ML Larson, JM Shammo, E Bogdanova, T Obrien, ... Blood 118 (21), 1616, 2011 | | 2011 |
| 9078 POSTER Anemia Due to Single Agent Pemetrexed, Requiring Transfusions, Despite Vitamin B12 and Folic Acid (FA) Supplementation S Gupta, S Pattali, KK Batra, ND Batra, T Braik, B Yim, T Lad European Journal of Cancer, S615, 2011 | | 2011 |
